[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma]. - Concepedia

Concepedia

Publication | Closed Access

[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma].

39

Citations

0

References

2007

Year

Xiao Dong Huang, Jun Yi, Guo Zhen Xu, Jin Jing, Wei Yang, Tai Xiang Lu, Shao Xiong Wu, Ren rui Wu, Wei Hu, Wei Xie,

Abstract

This phase 1 multicenter clinical trial shows that h-R3 in combination with radiotherapy is effective and well-tolerated for the treatment of locoregionally advanced nasopharyngeal carcinoma.